Cell Therapy Weekly: AI Collaboration to Predict CAR-T Response and Toxicity

RegMedNet · 10/22 16:22 UTC

The weekly roundup covers top cell and gene therapy news, including a research collaboration that will use BostonGene’s AI platform to model the longitudinal immune system. The aim is to identify predictive biomarkers of CAR-T response, toxicity, persistence and immune dynamics.

Read the original (RegMedNet)

See it in the digest → ・ See this issue →